| Related Articles |
Acinetobacter Pneumonia: Improving Outcomes with Early Identification and Appropriate Therapy.
Clin Infect Dis. 2018 May 05;:
Authors: Vazquez Guillamet C, Kollef MH
Abstract
In an era of increasing antimicrobial resistance, Acinetobacter distinguishes itself as one of the most resistant Gram-negative bacteria responsible for significant morbidity and mortality. New solutions are needed to combat the detrimental effects of increasing rates of antimicrobial resistance. Using empiric broad-spectrum antibiotics in patients deemed at risk for infections caused by multidrug-resistant pathogens may protect against attributable mortality but this temporary solution furthers the risk of antimicrobial resistance. In this article we will review relevant strategies to aid with early identification and appropriate treatment of Acinetobacter pneumonia while preserving antibiotic susceptibility.
PMID: 29741597 [PubMed - as supplied by publisher]